Search | Médecins Sans Frontières Access Campaign

2933 results found
There are 0 active filters

2933 results found

Hassan Abdedine, vaccinator of the Ministry of Public Health of Chad, on a vaccination site set up by MSF teams in Dini, Batha province, Chad.

Press release |

15 April 2024

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles

Tags Vaccines Gavi, the Vaccine Alliance

Letter |

08 April 2024

Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test

Letter from the Americas TB Coalition to Danaher and Cepheid to reduce the price of the XDR-TB test

Tags DiagnosticsTuberculosis

Letter |

02 April 2024

Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Letter from the national TB programme of Sierra Leone to Danaher and Cepheid to reduce the price of the XDR-TB test

Tags DiagnosticsTuberculosis tuberculosis Sierra Leone

Letter |

02 April 2024

Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Letter from the national TB programme of Belarus to Danaher and Cepheid to reduce the price of the XDR-TB test

Tags DiagnosticsTuberculosis Belarus

A close-up of Siwar holding her insulin pen. Siwar has type 1 diabetes and received her insulin pen from the MSF clinic in Arsal. Drawing on Siwar's experience, her father explains to how insulin pens make life easier for diabetic kids.

Press release |

27 March 2024

New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens

MSF study in JAMA estimates the costs of production of new diabetes drugs and insulin pens

Tags Diabetes Diabetes

Research article |

27 March 2024

JAMA Network Open: Estimated Sustainable Cost-Based Prices for Diabetes Medicines

MSF costing study in JAMA on diabetes drugs and insulin pens

Tags Diabetes Diabetes Insulin

Time for 5 - Why you need to sign our petition

Press release |

22 March 2024

‘Time for Five’ coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

MSF demands Danaher and Cepheid drop the price of all GeneXpert tests to $5 each

Tags Diagnostics Cepheid

Video |

22 March 2024

It’s Time for $5: Why are these lifesaving tests out of reach for so many people?

Sign the petition: https://timefor5.msfaccess.org/

Tags Diagnostics Time for $5

22 March 2024

Sign the petition now!

We call on Danaher and Cepheid to drop the price of lifesaving GeneXpert medical tests to $5 for all diseases

Infographic

Ebola treatments: How to make them accessible

Marking 10 years since the world’s deadliest Ebola outbreak on record, which killed more than 11,000 people in West Africa in 2014-2016, MSF provides this visual explainer about the currently available treatments for Ebola, and what is ...

Tags Tropical & neglected diseases

Medical staff providing treatment in MSF-supported Bolomba Ebola treatment center, Equateur province, DRC, August 2020

Press release |

18 March 2024

MSF calls for emergency stockpile of Ebola treatments ten years after world’s deadliest outbreak

Ten years after West Africa Ebola outbreak, MSF calls for global emergency stockpile of Ebola treatments

Tags Tropical & neglected diseases

Technical brief |

18 March 2024

Pandemic Agreement: MSF’s Comments on Selected Provisions of Revised Draft of Negotiating Text

While the new draft contains several improvements, governments must address outstanding issues to safeguard equitable access to medical products

Tags Pandemic preparedness

The MSF team prepare medical supplies to transport by motor boat to isolated communities in Delta Amacuro state, northeastern Venezuela.

Statement |

18 March 2024

Pandemic Agreement: MSF statement on revised draft of negotiating text

At INB9, governments must address outstanding issues to safeguard equitable access to medical products

Tags Pandemic preparedness TRIPS World Health Organization

6th October 2010: Wednesday in New Delhi, patients and activists stage a DIE-IN to protest at talks today between the European Union and the Indian government over a free trade agreement that could end production of life-saving affordable medicines for millions in need in developing countries.

Press release |

12 March 2024

MSF response to signing of EFTA-India trade agreement

Certain clauses in the trade deal could dilute use of public health measures under Indian patent law.

Tags Intellectual property and trade free trade agreementTRIPS SwitzerlandIndia

Thousands of demonstrators took to the streets in Delhi once again on 2 March 2011, in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.Thousands of demonstrators took to the streets in Delhi once again on 2 March in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.

Technical brief |

12 March 2024

MSF Comments on intellectual property provisions in the final agreement of India-EFTA Agreement

MSF technical analysis shares problematic clauses in EFTA India FTA trade agreement

Tags Intellectual property and trade free trade agreement SwitzerlandIndia

Letter |

05 March 2024

Letter: Civil society calls on European Parliament to support global access to medical tools by removing export prohibition in Union compulsory license

MSF and CSOs call for European support of access to medical tools through Union compulsory license

Tags Intellectual property and trade

A close-up photo shows pills in the hand of an MDR TB patient taking his Direct Observation Treatment Short Course (DOTs) medication at the Nhlangano TB Ward supported by MSF.

Press release |

29 February 2024

EU must drop all intellectual property provisions that go beyond WTO requirements in trade negotiations with India, as recommended in today’s SIA report

Millions of people around the world rely on affordable generic medicines and vaccines produced in India, the ‘Pharmacy of the Developing World’

Tags Intellectual property and trade free trade agreementTRIPS

Feature story |

29 February 2024

Our Wishlist for 2024

Our wishes for equitable access to medicines, tests and vaccines in 2024

Video |

27 February 2024

What to look out for in the Pandemic Accord: Stockpiling

MSF position on stockpiling in pandemic prevention, preparedness and response

Tags Pandemic preparedness World Health Organization

Technical brief |

22 February 2024

The PASTEUR Act is not the way for the US government to address antimicrobial resistance

The US PASTEUR Act falls short in addressing antimicrobial resistance

Tags Antimicrobial resistance

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test

Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test

New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens

JAMA Network Open: Estimated Sustainable Cost-Based Prices for Diabetes Medicines

‘Time for Five’ coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

It’s Time for $5: Why are these lifesaving tests out of reach for so many people?

Sign the petition now!

Ebola treatments: How to make them accessible

MSF calls for emergency stockpile of Ebola treatments ten years after world’s deadliest outbreak

Pandemic Agreement: MSF’s Comments on Selected Provisions of Revised Draft of Negotiating Text

Pandemic Agreement: MSF statement on revised draft of negotiating text

MSF response to signing of EFTA-India trade agreement

MSF Comments on intellectual property provisions in the final agreement of India-EFTA Agreement

Letter: Civil society calls on European Parliament to support global access to medical tools by removing export prohibition in Union compulsory license

EU must drop all intellectual property provisions that go beyond WTO requirements in trade negotiations with India, as recommended in today’s SIA report

Our Wishlist for 2024

What to look out for in the Pandemic Accord: Stockpiling

The PASTEUR Act is not the way for the US government to address antimicrobial resistance